Stay updated on Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:30:48.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Updated software version from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:04:15.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (up from v3.0.1). The 'Back to Top' link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T19:05:15.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T15:08:21.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed related to a clinical study. Additionally, several specific medical terms and conditions have been added, while some previous location details and related topics have been removed.
    Difference
    5%
    Check dated 2025-08-31T11:48:13.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:52:06.000Z thumbnail image

Stay in the know with updates to Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab/Olaparib Combo in Triple-Negative Breast Cancer Clinical Trial page.